Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126940391 | 12694039 | 1 | I | 2014 | 20160729 | 20160829 | 20160829 | PER | US-JNJFOC-20160727262 | JANSSEN | 0.00 | A | F | Y | 0.00000 | 20160829 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126940391 | 12694039 | 1 | PS | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | Y | N | 21121 | 36 | MG | SUSTAINED RELEASE TABLETS | TID | |||||
126940391 | 12694039 | 2 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126940391 | 12694039 | 1 | Attention deficit/hyperactivity disorder |
126940391 | 12694039 | 2 | Depression |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126940391 | 12694039 | Dysstasia | |
126940391 | 12694039 | Headache | |
126940391 | 12694039 | Nausea | |
126940391 | 12694039 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126940391 | 12694039 | 1 | 2014 | 201511 | 0 |